Nicole Prada

Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists

Takahiro Yamazaki, Dalil Hannani, Vichnou Poirier-Colame et al. · Cell Death and Differentiation · 2013 · 245 citations · Full text

Medicine, Immunology, Oncology +12

Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients

Michaëla Semeraro, Sylvie Rusakiewicz, Véronique Minard-Colin et al. · Science Translational Medicine · 2015 · 144 citations

Medicine, Immunology, Oncology +13

Characterization of cells with different mitochondrial membrane potential during apoptosis

Enrico Lugli, Leonarda Troiano, Roberta Ferraresi et al. · Cytometry Part A · 2005 · 139 citations · Full text

Life Sciences, Biochemistry, Cell Biology +15

Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer

Sylvain Ladoire, Frédérique Penault‐Llorca, Laura Senovilla et al. · Autophagy · 2015 · 101 citations · Full text

Medicine, Cell Biology, Oncology +16

Antitumor Immunity Triggered by Melphalan Is Potentiated by Melanoma Cell Surface–Associated Calreticulin

Aleksandra M. Dudek-Perić, Gabriela B. Ferreira, Angelika Muchowicz et al. · Cancer Research · 2015 · 99 citations · Full text

Medicine, Immunology, Oncology +17